Neulasta Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials

A Study of KRN125 in Patients With Multiple Myeloma and Malignant Lymphoma
Condition:   Multiple Myeloma and Malignant Lymphoma Interventions:   Drug: KRN125(pegfilgrastim), PLR001(plerixafor);   Drug: KRN8601(filgrastim), PLR001(plerixafor) Sponsor:   Kyowa Kirin Co., Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 16, 2021 Category: Research Source Type: clinical trials

Phase I/II Study to Reduce Post-transplantation Cyclophosphamide Dosing for Older or Unfit Patients Undergoing Bone Marrow Transplantation for Hematologic Malignancies
Condition:   Hematologic Neoplasms Interventions:   Drug: Mycophenolate Mofetil;   Procedure: Allogeneic HSCT;   Drug: Fludarabine;   Drug: Sirolimus;   Drug: Filgrastim;   Drug: Cyclophosphamide;   Drug: Mesna;   Procedure: Total Body Irradiation (TBI) Sponsor:   National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 13, 2021 Category: Research Source Type: clinical trials